|
1
|
Nilius B and Szallasi A: Transient
receptor potential channels as drug targets: From the science of
basic research to the art of medicine. Pharmacol Rev. 66:676–814.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barisoni L: Podocyte biology in segmental
sclerosis and progressive glomerular injury. Adv Chronic Kidney
Dis. 19:76–83. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Itoh M, Nakadate K, Horibata Y, Matsusaka
T, Xu J, Hunziker W and Sugimoto H: The structural and functional
organization of the podocyte filtration slits is regulated by
Tjp1/ZO-1. PLoS One. 9:e1066212014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shankland SJ: The podocyte's response to
injury: Role in proteinuria and glomerulosclerosis. Kidney Int.
69:2131–2147. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grishok A, Pasquinelli AE, Conte D, Li N,
Parrish S, Ha I, Baillie DL, Fire A, Ruvkun G and Mello CC: Genes
and mechanisms related to RNA interference regulate expression of
the small temporal RNAs that control C. elegans developmental
timing. Cell. 106:23–34. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li X and He JC: An update: The role of
Nephrin inside and outside the kidney. Sci China Life Sci.
58:649–657. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
May CJ, Saleem M and Welsh GI: Podocyte
dedifferentiation: A specialized process for a specialized cell.
Front Endocrinol (Lausanne). 5:1482014.
|
|
8
|
Gebeshuber CA, Kornauth C, Dong L, Sierig
R, Seibler J, Reiss M, Tauber S, Bilban M, Wang S, Kain R, et al:
Focal segmental glomerulosclerosis is induced by microRNA-193a and
its downregulation of WT1. Nat Med. 19:481–487. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin CL, Lee PH, Hsu YC, Lei CC, Ko JY,
Chuang PC, Huang YT, Wang SY, Wu SL, Chen YS, et al: MicroRNA-29a
promotion of nephrin acetylation ameliorates hyperglycemia-induced
podocyte dysfunction. J Am Soc Nephrol. 25:1698–1709. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu J, Zheng C, Fan Y, Zeng C, Chen Z, Qin
W, Zhang C, Zhang W, Wang X, Zhu X, et al: Downregulation of
microRNA-30 facilitates podocyte injury and is prevented by
glucocorticoids. J Am Soc Nephrol. 25:92–104. 2014. View Article : Google Scholar :
|
|
11
|
Shi S, Yu L, Zhang T, Qi H, Xavier S, Ju W
and Bottinger E: Smad2-dependent downregulation of miR-30 is
required for TGF-β-induced apoptosis in podocytes. PLoS One.
8:e755722013. View Article : Google Scholar
|
|
12
|
Yang X, Wang X, Nie F, Liu T, Yu X, Wang
H, Li Q, Peng R, Mao Z, Zhou Q, et al: miR-135 family members
mediate podocyte injury through the activation of Wnt/β-catenin
signaling. Int J Mol Med. 36:669–677. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang C, Chen X, Chen X, Wang X, Ji A,
Jiang L, Sang F and Li F: miR-135a acts as a tumor suppressor in
gastric cancer in part by targeting KIFC1. Onco Targets Ther.
9:3555–3563. 2016.PubMed/NCBI
|
|
14
|
Wan X, Pu H, Huang W, Yang S, Zhang Y,
Kong Z, Yang Z, Zhao P, Li A, Li T, et al: Androgen-induced
miR-135a acts as a tumor suppressor through downregulating RBAK and
MMP11, and mediates resistance to androgen deprivation therapy.
Oncotarget. 7:51284–51300. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamada Y, Hidaka H, Seki N, Yoshino H,
Yamasaki T, Itesako T, Nakagawa M and Enokida H: Tumor-suppressive
microRNA-135a inhibits cancer cell proliferation by targeting the
c-MYC oncogene in renal cell carcinoma. Cancer Sci. 104:304–312.
2013. View Article : Google Scholar
|
|
16
|
Wu S, Lin Y, Xu D, Chen J, Shu M, Zhou Y,
Zhu W, Su X, Zhou Y, Qiu P, et al: MiR-135a functions as a
selective killer of malignant glioma. Oncogene. 31:3866–3874. 2012.
View Article : Google Scholar
|
|
17
|
Nagel R, le Sage C, Diosdado B, van der
Waal M, Oude Vrielink JA, Bolijn A, Meijer GA and Agami R:
Regulation of the adenomatous polyposis coli gene by the miR-135
family in colorectal cancer. Cancer Res. 68:5795–5802. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Holleman A, Chung I, Olsen RR, Kwak B,
Mizokami A, Saijo N, Parissenti A, Duan Z, Voest EE and Zetter BR:
miR-135a contributes to paclitaxel resistance in tumor cells both
in vitro and in vivo. Oncogene. 30:4386–4398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou W, Li X, Liu F, Xiao Z, He M, Shen S
and Liu S: MiR-135a promotes growth and invasion of colorectal
cancer via metastasis suppressor 1 in vitro. Acta Biochim Biophys
Sin (Shanghai). 44:838–846. 2012. View Article : Google Scholar
|
|
20
|
Ni L, Saleem M and Mathieson PW: Podocyte
culture: Tricks of the trade. Nephrology (Carlton). 17:525–531.
2012. View Article : Google Scholar
|
|
21
|
Fogo AB: Animal models of FSGS: Lessons
for pathogenesis and treatment. Semin Nephrol. 23:161–171. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Wang YP, Tay YC and Harris DC:
Progressive adriamycin nephropathy in mice: Sequence of histologic
and immunohistochemical events. Kidney Int. 58:1797–1804. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mundel P, Reiser J, Zúñiga Mejía Borja A,
Pavenstädt H, Davidson GR, Kriz W and Zeller R: Rearrangements of
the cytoskeleton and cell contacts induce process formation during
differentiation of conditionally immortalized mouse podocyte cell
lines. Exp Cell Res. 236:248–258. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kolfschoten IG, van Leeuwen B, Berns K,
Mullenders J, Beijersbergen RL, Bernards R, Voorhoeve PM and Agami
R: A genetic screen identifies PITX1 as a suppressor of RAS
activity and tumorigenicity. Cell. 121:849–858. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bae GU, Lee JR, Kim BG, Han JW, Leem YE,
Lee HJ, Ho SM, Hahn MJ and Kang JS: Cdo interacts with APPL1 and
activates Akt in myoblast differentiation. Mol Biol Cell.
21:2399–2411. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Niehof M and Borlak J: HNF4 alpha and the
Ca-channel TRPC1 are novel disease candidate genes in diabetic
nephropathy. Diabetes. 57:1069–1077. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen K, Jin X, Li Q, Wang W, Wang Y and
Zhang J: Association of TRPC1 gene polymorphisms with type 2
diabetes and diabetic nephropathy in Han Chinese population. Endocr
Res. 38:59–68. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang D, Freedman BI, Flekac M, Santos E,
Hicks PJ, Bowden DW, Efendic S, Brismar K and Gu HF: Evaluation of
genetic association and expression reduction of TRPC1 in the
development of diabetic nephropathy. Am J Nephrol. 29:244–251.
2009. View Article : Google Scholar :
|
|
29
|
Liu S, Guo W, Shi J, Li N, Yu X, Xue J, Fu
X, Chu K, Lu C, Zhao J, et al: MicroRNA-135a contributes to the
development of portal vein tumor thrombus by promoting metastasis
in hepato-cellular carcinoma. J Hepatol. 56:389–396. 2012.
View Article : Google Scholar
|
|
30
|
Chen Y, Zhang J, Wang H, Zhao J, Xu C, Du
Y, Luo X, Zheng F, Liu R, Zhang H, et al: miRNA-135a promotes
breast cancer cell migration and invasion by targeting HOXA10. BMC
Cancer. 12:1112012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Q, Wang Y, Minto AW, Wang J, Shi Q,
Li X and Quigg RJ: MicroRNA-377 is up-regulated and can lead to
increased fibronectin production in diabetic nephropathy. FASEB J.
22:4126–4135. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Navarro A, Diaz T, Martinez A, Gaya A,
Pons A, Gel B, Codony C, Ferrer G, Martinez C, Montserrat E, et al:
Regulation of JAK2 by miR-135a: Prognostic impact in classic
Hodgkin lymphoma. Blood. 114:2945–2951. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Woudenberg-Vrenken TE, Bindels RJ and
Hoenderop JG: The role of transient receptor potential channels in
kidney disease. Nat Rev Nephrol. 5:441–449. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Reiser J, Polu KR, Möller CC, Kenlan P,
Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C,
et al: TRPC6 is a glomerular slit diaphragm-associated channel
required for normal renal function. Nat Genet. 37:739–744. 2005.
View Article : Google Scholar : PubMed/NCBI
|
